X-linked agammaglobulinemia is the most common type of primary immunodeficiency disorder. Mutation ofthe cytoplasmic tyrosine kinase gene, Btk (Bruton’s tyrosine kinase), is known to be the etiology of X-linked agammaglobulinemia. The patients with this disease manifest a B-cell deficiency and low levels of serum immunoglobulin;due to the deficient antibodies, they suffers from recurrent upper and lower respiratory infections. We report here a 24-year-old male with an initial clinical impression of recurrent pneumonia and bronchiectasis. The patient presented with marked pan-hypogammaglobulinemia and the absence of circulating B lymphocytes on the immunologic study, and he carried a splicing mutation of intron 2 in the Btk gene (IVS2 −3C>G).
1. Genevier HC, Hinshelwood S, Gaspar HB, Rigley KP, Brown D, Saeland S, et al. Expression of Bruton's yrosine kinase protein within the B cell lineage. Eur J Immunol 1994;24:3100-5.
2. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361:226-33.
3. Ochs HD, Smith CI. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine (Baltimore) 1996;75:287-99.
4. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006;85:193-202.
5. Lee AH, Levinson AI, Schumacher HR Jr. Hypogammaglobulinemia and rheumatic disease. Semin Arthritis Rheum 1993;22:252-64.
6. Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, Arai S, et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998;91:595-602.
7. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001;114:141-9.
8. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190-7.
9. Lee HJ, Ko JS, Kwon SS, Yoo JH, Min JK. A case of X-linked agammaglobulinemia with deletion of introns 15-18 of Btk gene mediated by Alu-Alu recombination. Korean J Med 2003;65:S798-S804.
10. Yu CM, Koh WJ, Kim KC, Lee BH, Hwang JH, Kang EH, et al. X-linked agammaglobulinemia associated with bronchiectasis: a case report. Tuberc Respir Dis 2003;54:628-34.
11. Kim YC, Choi IS, Lee MS, Park SS, Koh YI, Jung IJ, et al. A case of Bruton's agammaglobulinemia. Korean J Med 1994;47:721-6.
12. Jang SH, Kho WJ, Kim CH, Chung KH, Lee JH, Chung HS, et al. A case of X-linked agammaglobulinemia. Korean J Med 1997;53:426-30.
13. Kim HS, Chung CH, Shin YG, Lee MD, Kim MJ, Kim HY, et al. A case of X-linked agammaglobulinemia with delayed growth. J Korean Soc Endocrinol 1999;14:153-9.
14. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995;333:431-40.
15. Skull S, Kemp A. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93. Arch Dis Child 1996;74:527-30.